Neurol. praxi. 2016;17(4):257-262

Má smysl odlišovat kortikální a subkortikální demenci? Nemá

prof. MUDr. Irena Rektorová, Ph.D.1, 2, doc. MUDr. Stanislav Šutovský, PhD.3
1 Centrum pro kognitivní poruchy, 1. neurologická klinika LF MU a FN u sv. Anny, Brno
2 Vědecká skupina Aplikované neurovědy, CEITEC MU, Brno
3 I. neurologická klinika LF UK a UNB, Bratislava

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rektorová I, Šutovský S. Má smysl odlišovat kortikální a subkortikální demenci? Nemá. Neurol. praxi. 2016;17(4):257-262.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anderkova L, Eliasova I, Marecek R, Janousova E, Rektorova I. Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation. J Alzheimers Dis. 2015; 48: 251-260. Go to original source... Go to PubMed...
    2. Aybek S, Lazeyras F, Gronchi-Perrin A, Burkhard PR, Villemure JG, Vingerhoets FJ. Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease. Parkinsonism Relat Disord. 2009; 15: 521-524. Go to original source... Go to PubMed...
    3. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211. Go to original source... Go to PubMed...
    4. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707. Go to original source... Go to PubMed...
    5. Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 2005; 65: 1716-1722. Go to original source... Go to PubMed...
    6. Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010; 7: 1236-1248. Go to original source... Go to PubMed...
    7. Cho H, Kim JH, Kim C, Ye BS, Kim HJ, Yoon CW, Noh Y, Kim GH, Kim Y J, Kim CH, Kang SJ, Chin J, Kim ST, Lee KH, Na DL, Seong JK, Seo SW. Shape changes of the basal ganglia and thalamus in Alzheimer's disease: A three-year longitudinal study.J Alzheimers Dis 2014; 40: 285-295. Go to original source... Go to PubMed...
    8. Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, Takeuchi T, Kazui H, Koyama H. Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo). 2008; 48(Suppl): S1-23. Go to original source... Go to PubMed...
    9. Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012; 27: 349-356. Go to original source... Go to PubMed...
    10. Marmarou A, Bergsneider M, Relkin N, Klinge P, Black PM. Development of guidelines for idiopathic normal-pressure hydrocephalus: introduction.Neurosurgery. 2005; 57(3 Suppl): S1-3; discussion ii-v. Go to original source... Go to PubMed...
    11. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269. Go to original source... Go to PubMed...
    12. Quadri M, Cossu G, Saddi V, Simons EJ, Murgia D, Melis M, Ticca A, Oostra BA, Bonifati V. Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia. Neurogenetics 2011; 12: 203-209. Go to original source... Go to PubMed...
    13. Rektorová I. Nová klinická kritéria pro diagnostiku Alzheimerovy nemoci po 27 letech. Neurol. praxi 2012; 13: 68-71.
    14. Rektorová I. Současné možnosti diagnostiky a terapie Parkinsonovy nemoci. Neurol. praxi 2009; 10(1)(Suppl. A): 38 stran.
    15. Rektorova I, Biundo R, Marecek R, Weis L, Aarsland D, Antonini A. Grey matter changes in cognitively impaired Parkinson's disease patients. PLoS One 2014; 9: e85595. Go to original source... Go to PubMed...
    16. Rektorova I, Matej R. Anterior opercular syndrome in frontotemporal lobar degeneration with ubiquitin-only immunoreactive neuronal changes. Eur J Neurol 2007; 14: 697-700. Go to original source... Go to PubMed...
    17. Rektorova I, Rusina R, Hort J, Matej R. The Degenerative Dementias. In: Lisak RP, Truong DD, Carroll WM, Bhidayasiri R (eds.). International neurology: A clinical approach. Blackwsell Publishing 2009: 126-136. Go to original source...
    18. Rektorova I, Srovnalova H, Kubikova R, Prasek J. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease. Mov Disord 2008; 23: 1580-1587. Go to original source... Go to PubMed...
    19. Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V, Sheardová K. Doporučené postupy pro diagnostiku Alzheimerovy nemoci a ostatních demencí. Neurol. praxi 2009; 10: 237-241.
    20. Rusina R, Kovacs GG, Fiala J, Hort J, Ridzoň P, Holmerová I, Ströbel T, Matěj R. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases. BMC Neurol 2011; 11: 50. Go to original source... Go to PubMed...
    21. Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu BO, Rektorova I, Religa D, Rusina R, Rossor M, Schmidt R, Stefanova E, Warren JD, Scheltens P; EFNS Scientist Panel on Dementia and Cognitive Neurology. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012; 19: 1159-1179. Go to original source... Go to PubMed...
    22. Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron 2014; 84: 608-622. Go to original source... Go to PubMed...
    23. Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 2012; 135: 170-180. Go to original source... Go to PubMed...
    24. ##
    25. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010; 9: 1118-1127. Go to original source... Go to PubMed...
    26. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rock wood K, Roman GC, Chui H, Desmond DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transam 2000; 59: 23-30. Go to original source... Go to PubMed...
    27. Erkinjuntti T, Gauthier S. The concept of vascular cognitive impairment. Front Neurol Neurosci 2009; 24: 79-85. Go to original source... Go to PubMed...
    28. Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci. 2007; 257: 80-7. Review. Go to original source... Go to PubMed...
    29. Jellinger KA. Understanding the pathology of vascular cognitive impairment. J Neurol Sci. 2005; 229-230:57-63. Go to original source... Go to PubMed...
    30. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology. 1993; 43:250-260. Go to original source... Go to PubMed...
    31. Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain. 2011; 134(Pt 9): 2478-2492. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.